Dilated cardiomyopathy and pregnancy. Clinical observation of successful delivery and literature review

References

[1] Grewal J., Siu S. C., Ross H. J. et al. Pregnancy outcomes in women with dilated cardiomyopathy // J. Am. Coll. Cardiol. 2009 Dec 29; 55(1): 45-52.

[2] Why Mothers Die 2000-2002. Confidential Enquiry into Maternal and Child Health. RCOG Press, London, 2004.

[3] Why Mothers Die 1997-99. The Confidential Enquiries into Maternal Deaths in the United Kingdom. RCOG Press, London, 2001.

[4] Why Mothers Die 1994-96. The Confidential Enquiries into Maternal Deaths in the United Kingdom. RCOG Press, London, 1998.

[5] Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1991-93. HMSO, London, 1996.

[6] Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1988-90. HMSO, London, 1994.

[7] Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1985-87. HMSO, London, 1991.

[8] Report on Confidential Enquiries into Maternal Deaths in England and Wales 1982-84. HMSO, London, 1989.

[9] Whitehead S. J., Berg S. J., Chang J. Pregnancy-related mortality due to cardiomyopathy: United States, 1991-1997 // Obstet. Gynecol. 2003; 102: 1326-1331.

[10] Pearson G., Veille J. C., Rahimtoola S. et al. Peripartum cardiomyopathy. National Heart, Lung and Blood Institute and Office of Rare Diseases. Workshop recommendations and review // JAMA. 2000; 283: 1183-1188.

[11] Ro A., Frishman W. H. Peripartum Cardiomyopathy // Cardiol. Rev. 2006; 14: 35-42.

[12] Ray P., Murphy G. J., Shutt L. E. Recognition and management of maternal cardiac disease in pregnancy // Br. J. Anaesth. 2004; 93: 428-439.

[13] Elliott P., McKenna W. J. Hypertrophic cardiomyopathy // Lancet. 2004; 363: 1881-1891.

[14] Thaman R., Varnava A., Hamid M. S. et al. Pregnancy related complications in women with hypertrophic cardiomyopathy // Heart. 2003; 89: 752-756.

[15] Pellicia F., Cianfrocca C., Gaudio C., Reale A. Sudden death during pregnancy in hypertrophic cardiomyopathy // Eur. Heart. J. 1992; 13: 421-423.

[16] Lewis N. L., Dob D. P., Yentis S. M. UK registry of highrisk obstetric anaesthesia: arrhythmias, cardiomyopathy, aortic stenosis, transposition of the great arteries and Marfan’s syndrome // Int. J. Obstet. Anesth. 2003; 12: 28-34.

[17] Heider A. L., Kuller J. A., Strauss R. A., Wells S. R. Peripartum cardiomyopathy: a review of the literature // Obstet. Gynecol. Surv. 1999; 54: 526-531.

[18] George L. M., Gatt S. P., Lowe S. Peripartum cardiomyopathy: four case histories and a commentary on anaesthetic management // Anaesth. Intensive Care. 1997; 25: 292-296.

[19] Pirlet M., Baird M., Pryn S. et al. Low dose combined spinalepidural anaesthesia for caesarean section in a patient with peripartum cardiomyopathy // Int. J. Obstet. Anesth. 2000; 9: 189-192.

[20] Autore A., Brauneis S., Apponi F. et al. Epidural anesthesia for cesarean section in patients with Hypertrophic Cardiomyopathy: a report of three cases // Anesthesiology. 1999; 90: 1205-1207.

[21] Gould T. S. J., Elliott J., Foweraker M. et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy // J. Antimicrob. Chemother. 2006; 57: 1035-1042.

[22] Pinder A. J., Dresner M., Calow C. et al. Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia // Int. J. Obstet. Anesth. 2002; 11: 156-159.

[23] Task Force on Acute Heart Failure of the European Society of Cardiology. Guidelines on the diagnosis and treatment of acute heart failure // Sophia Antipolis: European Society of Cardiology; 2005.

[24] Sharma B., Goodwin J. F. Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle // Circulation. 1978; 58: 449-460.

RIGHTS & PERMISSIONS

Eco-Vector